Tacrolimus: review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate practitioners' understanding and offer strategies for educating patients and promoting adherence.
about
Face allotransplantation and burns: a reviewTacrolimus does not affect early wound healing in a rodent model of bowel anastomoses and abdominal wall closure.Current principles of facial allotransplantation: the Brigham and Women's Hospital ExperienceThe neuroregenerative mechanism mediated by the Hsp90-binding immunophilin FKBP52 resembles the early steps of neuronal differentiation.Validation of tacrolimus equation to predict troughs using genetic and clinical factors.Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortiumUse of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator.Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant.Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations.Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.Future of the pharmacogenomics of calcineurin inhibitors in renal transplant patients.Norisoboldine, an alkaloid from Radix linderae, inhibits NFAT activation and attenuates 2,4-dinitrofluorobenzene-induced dermatitis in mice.
P2860
Q27005853-A9EBCEDC-9836-4DAC-9CCA-C48090E17D17Q35006318-BB0711E8-3F2F-4ECE-9EB7-7C5DEC4E8446Q35218505-5A22862F-17C9-4940-B951-D8C5EA401034Q36159195-65FAC059-50F8-4EFC-9686-DB6A880B7BDBQ36630077-6148BAE6-E018-4234-B226-2BD3FF8033C9Q36630081-E5114E29-D08C-4400-9B75-AE3986437ECAQ37587285-A300AC49-6773-4377-8F17-EADCE39E73FCQ37772515-10C011C8-AE9E-4609-82F3-D8FE44546470Q38269284-F2AFABDB-4AF0-4490-B033-DE018FFB9439Q38749645-1C8BDB43-659B-424C-9438-294DE631F6E2Q51664949-38D12A0F-B7F3-4D59-8F85-B7D36F70A00FQ51697569-AD60ADBA-352B-4134-A02C-D023523BEA47
P2860
Tacrolimus: review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate practitioners' understanding and offer strategies for educating patients and promoting adherence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tacrolimus: review of pharmaco ...... ients and promoting adherence.
@en
Tacrolimus: review of pharmaco ...... ients and promoting adherence.
@nl
type
label
Tacrolimus: review of pharmaco ...... ients and promoting adherence.
@en
Tacrolimus: review of pharmaco ...... ients and promoting adherence.
@nl
prefLabel
Tacrolimus: review of pharmaco ...... ients and promoting adherence.
@en
Tacrolimus: review of pharmaco ...... ients and promoting adherence.
@nl
P2093
P2860
P1476
Tacrolimus: review of pharmaco ...... ients and promoting adherence.
@en
P2093
Danella Young
Michele Vicari-Christensen
Sharon Basile
Suzanne Repper
P2860
P304
P356
10.7182/PRTR.19.3.22U4114WN0L01140
P577
2009-09-01T00:00:00Z